Therefore, the prognosis of IGFBP2 in underlying mechanism should be explored, and whether pathways of IGFBP2 mediated are helpful in treatment of glioma and colorectal cancer patients needs to be confirmed through more fundamental research. The gene discussed is IGFBP2; the disease is glioma.